Text this: 389 ENHANCING VIRUS-SPECIFIC IMMUNITY IN VIVO BY COMBINING THERAPEUTIC VACCINATION AND PD1/PD-L1 BLOCKADE IN CHRONIC HEPADNAVIRAL INFECTION.